Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast
Diagnostic Cytopathology, 10/02/09
Facina G et al. – E–cadherin (EC) is an important glycoprotein cell–adhesion molecule that appears to play a significant role in the progression of breast lesions. The present findings point to a significant association between reduced EC expression and the progression and aggressivity of breast lesions.
Related Articles
E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study
Breast Cancer Research and Treatment, 10/23/09
Relevance Score: 84%
N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin
Human Pathology, 10/08/09
Relevance Score: 80%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer
Cancer Treatment Reviews, 12/04/09
Dysregulation of Platelet-Derived Growth Factor beta-Receptor Expression by deltaNp73 in Neuroblastoma
Molecular Cancer Research, 12/04/09
Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression
Virchows Archiv, 12/04/09
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Bevacizumab and breast cancer: current therapeutic progress and future perspectives
Expert Review of Anticancer Therapy, 12/04/09
Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis
Cancer Treatment Reviews, 12/04/09
Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
Cancer Treatment Reviews, 12/04/09
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Malignant granular cell tumor: case report with a novel karyotype and review of the literature
Annals of Diagnostic Pathology, 12/04/09
Concurrent diagnoses of Hodgkin lymphoma and biclonal myeloma in the bone marrow
Annals of Diagnostic Pathology, 12/04/09
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma
Journal of Cancer Research & Clinical Oncology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


